{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:25:50Z","timestamp":1779891950508,"version":"3.53.1"},"reference-count":39,"publisher":"American Diabetes Association","issue":"1","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To estimate medical costs associated with 17 diabetes complications and treatment procedures among Medicare beneficiaries aged \u226565 years with type 1 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>With use of the 2006\u20132017 100% Medicare claims database for beneficiaries enrolled in fee-for-service plans and Part D, we estimated the annual cost of 17 diabetes complications and treatment procedures. Type 1 diabetes and its complications and procedures were identified using ICD-9\/ICD-10, procedure, and diagnosis-related group codes. Individuals with type 1 diabetes were followed from the year when their diabetes was initially identified in Medicare (2006\u20132015) until death, discontinuing plan coverage, or 31 December 2017. Fixed-effects regression was used to estimate costs in the complication occurrence year and subsequent years. The cost proportion of a complication was equal to the total cost of the complication, calculated by multiplying prevalence by the per-person cost divided by the total cost for all complications. All costs were standardized to 2017 U.S. dollars.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Our study included 114,879 people with type 1 diabetes with lengths of follow-up from 3 to 10 years. The costliest complications per person were kidney failure treated by transplant ($77,809 in the occurrence year and $13,556 in subsequent years), kidney failure treated by dialysis ($56,469 and $41,429), and neuropathy treated by lower-extremity amputation ($40,698 and $7,380). Sixteen percent of the total medical cost for diabetes complications was for treating congestive heart failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Costs of diabetes complications were large and varied by complications. Our results can assist in cost-effectiveness analysis of treatments and interventions for preventing or delaying diabetes complications in Medicare beneficiaries aged \u226565 years with type 1 diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc21-2538","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T16:15:43Z","timestamp":1668788143000},"page":"149-155","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":10,"title":["Medical Costs Associated With Diabetes Complications in Medicare Beneficiaries Aged 65 Years or Older With Type 1 Diabetes"],"prefix":"10.2337","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4740-6406","authenticated-orcid":false,"given":"Yu","family":"Wang","sequence":"first","affiliation":[{"name":"1Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8429-6301","authenticated-orcid":false,"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shao","sequence":"additional","affiliation":[{"name":"1Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA"},{"name":"2Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda J.","family":"Andes","sequence":"additional","affiliation":[{"name":"1Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Imperatore","sequence":"additional","affiliation":[{"name":"1Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"2022122220000150100_B1","first-page":"12","volume-title":"Prevention. National Diabetes Statistics Report, 2020","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"2022122220000150100_B2","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1001\/jama.2014.3201","article-title":"Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009","volume":"311","author":"Dabelea","year":"2014","journal-title":"JAMA"},{"key":"2022122220000150100_B3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","article-title":"Incidence trends of type 1 and type 2 diabetes among youths, 2002\u20132012","volume":"376","author":"Mayer-Davis","year":"2017","journal-title":"N Engl J Med"},{"key":"2022122220000150100_B4","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.2337\/db11-1625","article-title":"Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort","volume":"61","author":"Miller","year":"2012","journal-title":"Diabetes"},{"key":"2022122220000150100_B5","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/bmj.320.7246.1373","article-title":"Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)","volume":"320","author":"Gray","year":"2000","journal-title":"BMJ"},{"key":"2022122220000150100_B6","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2337\/dci20-0017","article-title":"Cost-effectiveness of interventions to manage diabetes: has the evidence changed since 2008?","volume":"43","author":"Siegel","year":"2020","journal-title":"Diabetes Care"},{"key":"2022122220000150100_B7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40273-015-0374-8","article-title":"A systematic review of cost-effectiveness models in type 1 diabetes mellitus","volume":"34","author":"Henriksson","year":"2016","journal-title":"PharmacoEconomics"},{"key":"2022122220000150100_B8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2431-13-55","article-title":"Healthcare cost of type 1 diabetes mellitus in new-onset children in a hospital compared to an outpatient setting","volume":"13","author":"Jasinski","year":"2013","journal-title":"BMC Pediatr"},{"key":"2022122220000150100_B9","doi-asserted-by":"crossref","first-page":"e11501","DOI":"10.1371\/journal.pone.0011501","article-title":"Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method","volume":"5","author":"Tao","year":"2010","journal-title":"PLoS One"},{"key":"2022122220000150100_B10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2337\/dc13-2176","article-title":"Burden of diabetic foot ulcers for Medicare and private insurers","volume":"37","author":"Rice","year":"2014","journal-title":"Diabetes Care"},{"key":"2022122220000150100_B11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00592-015-0755-7","article-title":"Short-term cost analysis of complications related to glycated hemoglobin in patients with type 1 diabetes in the Italian setting","volume":"53","author":"Nicolucci","year":"2016","journal-title":"Acta Diabetol"},{"key":"2022122220000150100_B12","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2337\/dc05-2470","article-title":"Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes","volume":"29","author":"Eppens","year":"2006","journal-title":"Diabetes Care"},{"key":"2022122220000150100_B13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.0686","article-title":"Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood","volume":"317","author":"Dabelea","year":"2017","journal-title":"JAMA"},{"key":"2022122220000150100_B14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1464-5491.2004.01391.x","article-title":"The annual incidence of diabetic complications in a population of patients with type 1 and type 2 diabetes","volume":"22","author":"McAlpine","year":"2005","journal-title":"Diabet Med"},{"key":"2022122220000150100_B15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1464-5491.2005.01501.x","article-title":"Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study","volume":"22","author":"Donnelly","year":"2005","journal-title":"Diabet Med"},{"key":"2022122220000150100_B16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.15585\/mmwr.mm6843a2","article-title":"Diabetes prevalence and incidence among Medicare beneficiaries - United States, 2001\u20132015","volume":"68","author":"Andes","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022122220000150100_B17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2288-9-62","article-title":"Optimal strategy to identify incidence of diagnostic of diabetes using administrative data","volume":"9","author":"Asghari","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"2022122220000150100_B18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/pedi.12152","article-title":"Use of administrative and electronic health record data for development of automated algorithms for childhood diabetes case ascertainment and type classification: the SEARCH for Diabetes in Youth Study","volume":"15","author":"Zhong","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"2022122220000150100_B19","unstructured":"Centers for Medicare & Medicaid Services\n          . Medicare Advantage Rates & Statistics. 2021. Accessed 29 November 2021. Available from https:\/\/www.cms.gov\/Medicare\/Health-Plans\/MedicareAdvtgSpecRateStats"},{"key":"2022122220000150100_B20","unstructured":"Health Economics Resource Center\n          . Measuring Costs for Cost-Effectiveness Analysis. Accessed 8 February 2022. Available from https:\/\/www.herc.research.va.gov\/include\/page.asp?id=measure-costs-cea"},{"key":"2022122220000150100_B21","first-page":"2","article-title":"Panel data: fixed and random effects","volume":"7","author":"Schmidheiny","year":"2011","journal-title":"Short Guides Microeconometrics"},{"key":"2022122220000150100_B22","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2337\/db05-1423","article-title":"The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience","volume":"55","author":"Pambianco","year":"2006","journal-title":"Diabetes"},{"key":"2022122220000150100_B23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1464-5491.2004.01183.x","article-title":"Cost-effectiveness of flexible intensive insulin management to enable dietary freedom in people with type 1 diabetes in the UK","volume":"21","author":"Shearer","year":"2004","journal-title":"Diabet Med"},{"key":"2022122220000150100_B24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s001250050003","article-title":"The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective","volume":"43","author":"Palmer","year":"2000","journal-title":"Diabetologia"},{"key":"2022122220000150100_B25","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/bmj.306.6894.1722","article-title":"Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?","volume":"306","author":"Borch-Johnsen","year":"1993","journal-title":"BMJ"},{"key":"2022122220000150100_B26","doi-asserted-by":"crossref","first-page":"107735","DOI":"10.1016\/j.jdiacomp.2020.107735","article-title":"Estimating costs of diabetes complications in people &lt;65 years in the U.S. using panel data","volume":"34","author":"Yang","year":"2020","journal-title":"J Diabetes Complications"},{"key":"2022122220000150100_B27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2337\/ds18-0033","article-title":"Diabetes management in the elderly","volume":"31","author":"Leung","year":"2018","journal-title":"Diabetes Spectr"},{"key":"2022122220000150100_B28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc17-1763","article-title":"Health care costs associated with incident complications in patients with type 2 diabetes in Germany","volume":"41","author":"K\u00e4hm","year":"2018","journal-title":"Diabetes Care"},{"key":"2022122220000150100_B29","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1185\/030079905X65349","article-title":"Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain","volume":"21","author":"Ray","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"2022122220000150100_B30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.2003.00972.x","article-title":"The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65)","volume":"20","author":"Clarke","year":"2003","journal-title":"Diabet Med"},{"key":"2022122220000150100_B31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1524-4733.2007.00228.x","article-title":"Estimating the cost of complications of diabetes in Australia using administrative health-care data","volume":"11","author":"Clarke","year":"2008","journal-title":"Value Health"},{"key":"2022122220000150100_B32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00019053-200927010-00008","article-title":"Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data","volume":"27","author":"Gerdtham","year":"2009","journal-title":"PharmacoEconomics"},{"key":"2022122220000150100_B33","doi-asserted-by":"crossref","first-page":"1015-P","DOI":"10.2337\/db21-1015-P","article-title":"Cost of diabetes complications in U.S. adults aged 65 years or older","volume":"70","author":"Wang","year":"2021","journal-title":"Diabetes"},{"key":"2022122220000150100_B34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.2337\/diacare.26.4.1176","article-title":"Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use","volume":"26","author":"Leese","year":"2003","journal-title":"Diabetes Care"},{"key":"2022122220000150100_B35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3111\/13696998.2015.1006730","article-title":"Economic impact of severe and non-severe hypoglycemia in patients with type 1 and type 2 diabetes in the United States","volume":"18","author":"Foos","year":"2015","journal-title":"J Med Econ"},{"key":"2022122220000150100_B36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199000394-00004","article-title":"Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function","volume":"39","author":"Ljungman","year":"1990","journal-title":"Drugs"},{"key":"2022122220000150100_B37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00041552-200403000-00004","article-title":"The association between congestive heart failure and chronic renal disease","volume":"13","author":"Silverberg","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2022122220000150100_B38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jacc.2012.10.011","article-title":"A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure","volume":"61","author":"Savarese","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022122220000150100_B39","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/MLR.0000000000000565","article-title":"Social determinants of health, cost-related nonadherence, and cost-reducing behaviors among adults with diabetes: findings from the National Health Interview Survey","volume":"54","author":"Patel","year":"2016","journal-title":"Med Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/46\/1\/149\/694784\/dc212538.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/46\/1\/149\/694784\/dc212538.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T15:00:22Z","timestamp":1671721222000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/46\/1\/149\/147945\/Medical-Costs-Associated-With-Diabetes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,11,18]]},"published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc21-2538","relation":{"has-preprint":[{"id-type":"doi","id":"10.2337\/figshare.21404937.v1","asserted-by":"object"},{"id-type":"doi","id":"10.2337\/figshare.21404937","asserted-by":"object"}]},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]}}}